article Open AccessTop 1% cited

p63 Is a Prostate Basal Cell Marker and Is Required for Prostate Development

American Journal Of Pathology · 2000 · Vol. 157(6) · pp. 1769–1775

Sabina Signoretti(Brigham and Women's Hospital)David Waltregny(Dana-Farber Cancer Institute)James R. Dilks(Dana-Farber Cancer Institute)Beth Isaac(Dana-Farber Cancer Institute)Douglas I. Lin(Dana-Farber Cancer Institute)Levi A. Garraway(Dana-Farber Cancer Institute)Annie Yang(Harvard University)Rodolfo Montironi(Ospedali Riuniti di Ancona)Frank McKeon(Harvard University)Massimo Loda✉(Brigham and Women's Hospital)

View via DOI Publisher page

Cancer-related Molecular Pathways Urological Disorders and Treatments Epigenetics and DNA MethylationProstateBasal (medicine)BiologyProstate cancerImmunohistochemistryCancer researchPathologyMedicineInternal medicineEndocrinology

MeSH terms

AdenocarcinomaAnimalsCell NucleusCells, CulturedDNA-Binding ProteinsEpithelial CellsHumansMaleMembrane ProteinsMice, Inbred StrainsNeoplasm InvasivenessPhosphoproteinsProstateProstatic NeoplasmsReference Values

Citations

608

FWCI

13.99

field-weighted impact

References

Percentile

99%

vs. same field & year

Citations per year

Cited by

Diagnostic utility of immunohistochemistry using basal cell markers in distinguishing benign from malignant prostatic lesions